Related Experiment Video
Updated: Mar 14, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Paratesticular Rhabdomyosarcoma Associated with Tuberculosis
Neriman Sari1, Nurettin Okur1, Gulin Uçmak2
1Department of Pediatric Hematology and Oncology, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey.
Diagnosing paratesticular rhabdomyosarcoma alongside tuberculosis (TB) lymphadenitis is critical. Early evaluation of unexpected lymphadenopathies prevents misdiagnosis and harmful treatments in cancer patients.
Area of Science:
- Oncology
- Infectious Diseases
- Pediatric Medicine
Background:
- Rhabdomyosarcoma is a rare soft tissue sarcoma in children and adolescents.
- Tuberculosis (TB) remains a significant global health issue, particularly in developing nations.
- Accurate diagnosis is crucial for effective treatment and patient outcomes.
Observation:
- A 16-year-old male presented with paratesticular rhabdomyosarcoma and mediastinal tuberculous lymphadenitis.
- The differential diagnosis between rhabdomyosarcoma staging and TB was challenging due to the absence of a prior TB history.
- Unexpected lymphadenopathies during malignancy staging require thorough investigation.
Findings:
- The case highlights the importance of considering tuberculosis (TB) in the differential diagnosis of unexpected lymphadenopathies in cancer patients.
- Misdiagnosis can lead to inappropriate treatments, potentially worsening cancer staging and patient prognosis.
- Tuberculosis reactivation is a risk during chemotherapy due to immunosuppression.
Implications:
- Clinicians should maintain a high index of suspicion for TB in patients with unexplained lymphadenopathy, especially in endemic areas.
- Integrating infectious disease screening into cancer staging protocols can improve diagnostic accuracy.
- Prompt and correct diagnosis prevents unnecessary morbidity and mortality associated with delayed or incorrect cancer treatment.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
09:21Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...